Grace Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHNCT05995405GTX-104, Nimotop 30 MG Oral CapsuleActive not recruiting2024-12Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.